“The first-in-human clinical application of permanent wireless pressure monitoring in an LVAD patient has proven the feasibility of the device as well as the safe and continuous detection of hemodynamic parameters. This new technology offers a viable and needed option for wireless, continuous right heart monitoring in heart failure patients for the first 30 days after LVAD implantation.”
We congratulate Zurab Darbaidze, Jasmin S. Hanke, Günes Dogan, Bastian Schmack, Arjang Ruhparwar and Jan D. Schmitto from the Medizinische Hochschule Hannover for their case report about first in human use of CorLog in a LVAD patient: https://onlinelibrary.wiley.com/doi/10.1111/aor.14690
